Found 376 matching trials
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor PHASE2 The purpose of this study is to determine whether ATIR is safe and effectiv...
Show More Location
Algemeen Ziekenhuis Sint-Jan
Learn More & Join Trial
Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCT PHASE1 The purposes of the study are to determine the maximum tolerated dose (MTD)...
Show More Status
Active Not Recruiting
Location
Moffitt Cancer Center
Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders PHASE2 This phase II clinical trial studies how well treosulfan, thiotepa, fludara...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Busulfan and Cyclophosphamide Followed By ALLO BMT NA This is a treatment guideline to allow routine clinical data to be collecte...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps PHASE1 This is a research study involving the treatment of patients with hematolog...
Show More Location
Thomas Jefferson University
Learn More & Join Trial
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL. PHASE2 RATIONALE: - Relapsed or refractory Neuroblastoma (NBL) carries a very poor...
Show More Location
Children's Memorial Hospital
Learn More & Join Trial
Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant PHASE2 This phase II trial studies pentostatin and donor lymphocyte infusion in pr...
Show More Location
Huntsman Cancer Institute/University of Utah
Learn More & Join Trial
Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies PHASE1 This single arm pilot phase I study with safety run-in is designed to estim...
Show More Location
Washington University School of Medicine
Learn More & Join Trial